Ireland

--:--IST

Latest

Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide

Subscribe

Registers› Irish medicines ›Pomalidomide

Medicines register · Ireland

Pomalidomide — medicines in Ireland

36 authorised products containing Pomalidomide, from the HPRA register.

Source: HPRA open dataset ("Authorised or Transfer Pending Products"), CC BY 4.0. Complete coverage — all 10,295 authorised products are in this register. Synced 06 Oct 2026, 03:23 UTC

Narrow the register Reset

Search within results

Matches brand name, active substance, licence holder and licence number.

Browse by first letter

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0–9

Medicine

Active substance

Licence holder

Status

Imnovid 1 mg hard capsules EU/1/13/850/001

Pomalidomide

Bristol-Myers Squibb Pharma EEIG

—

Imnovid 2 mg hard capsules EU/1/13/850/002

Pomalidomide

Bristol-Myers Squibb Pharma EEIG

—

Imnovid 3 mg hard capsules EU/1/13/850/003

Pomalidomide

Bristol-Myers Squibb Pharma EEIG

—

Imnovid 4 mg hard capsules EU/1/13/850/004

Pomalidomide

Bristol-Myers Squibb Pharma EEIG

—

Pomalidomide Accord 1 mg hard capsules EU/1/24/1831/001-006

Pomalidomide

Accord Healthcare S.L.U.

—

Pomalidomide Accord 2 mg hard capsules EU/1/24/1831/007-012

Pomalidomide

Accord Healthcare S.L.U.

—

Pomalidomide Accord 3 mg hard capsules EU/1/24/1831/013-018

Pomalidomide

Accord Healthcare S.L.U.

—

Pomalidomide Accord 4 mg hard capsules EU/1/24/1831/019-024

Pomalidomide

Accord Healthcare S.L.U.

—

Pomalidomide Clonmel 1 mg hard capsules PA0126/378/001

Pomalidomide

Clonmel Healthcare Ltd

Marketed

Pomalidomide Clonmel 2 mg hard capsules PA0126/378/002

Pomalidomide

Clonmel Healthcare Ltd

Marketed

Pomalidomide Clonmel 3 mg hard capsules PA0126/378/003

Pomalidomide

Clonmel Healthcare Ltd

Marketed

Pomalidomide Clonmel 4 mg hard capsules PA0126/378/004

Pomalidomide

Clonmel Healthcare Ltd

Marketed

Pomalidomide Grindeks 1 mg hard capsule PA22992/022/001

Pomalidomide

Not marketed

Pomalidomide Grindeks 2 mg hard capsule PA22992/022/002

Pomalidomide

Not marketed

Pomalidomide Grindeks 3 mg hard capsule PA22992/022/003

Pomalidomide

Not marketed

Pomalidomide Grindeks 4 mg hard capsule PA22992/022/004

Pomalidomide

Not marketed

Pomalidomide Krka 1 mg hard capsules EU/1/24/1832/001-002

Pomalidomide

Krka, d.d., Novo mesto

—

Pomalidomide Krka 2 mg hard capsules EU/1/24/1832/003-004

Pomalidomide

Krka, d.d., Novo mesto

—

Pomalidomide Krka 3 mg hard capsules EU/1/24/1832/005-006

Pomalidomide

Krka, d.d., Novo mesto

—

Pomalidomide Krka 4 mg hard capsules EU/1/24/1832/007-008

Pomalidomide

Krka, d.d., Novo mesto

—

Pomalidomide Rowex 1 mg hard capsules PA0711/338/001

Pomalidomide

Not marketed

Pomalidomide Rowex 2 mg hard capsules PA0711/338/002

Pomalidomide

Marketed

Pomalidomide Rowex 3 mg hard capsules PA0711/338/003

Pomalidomide

Marketed

Pomalidomide Rowex 4 mg hard capsules PA0711/338/004

Pomalidomide

Marketed

Pomalidomide Teva 1 mg Capsule, hard EU/1/24/1868/001-012

Pomalidomide

—

Pomalidomide Teva 2 mg Capsule, hard EU/1/24/1868/013-024

Pomalidomide

—

Pomalidomide Teva 3 mg Capsule, hard EU/1/24/1868/025-036

Pomalidomide

—

Pomalidomide Teva 4 mg Capsule, hard EU/1/24/1868/037-048

Pomalidomide

—

Pomalidomide Viatris 1 mg hard capsules EU/1/23/1785/001-004

Pomalidomide

Viatris Limited

—

Pomalidomide Viatris 2 mg hard capsules EU/1/23/1785/005-008

Pomalidomide

Viatris Limited

—

Pomalidomide Viatris 3 mg hard capsules EU/1/23/1785/009-012

Pomalidomide

Viatris Limited

—

Pomalidomide Viatris 4 mg hard capsules EU/1/23/1785/013-016

Pomalidomide

Viatris Limited

—

Pomalidomide Zentiva 1 mg hard capsules EU/1/24/1830/001-004

Pomalidomide

—

Pomalidomide Zentiva 2 mg hard capsules EU/1/24/1830/005-008

Pomalidomide

—

Pomalidomide Zentiva 3 mg hard capsules EU/1/24/1830/009-012

Pomalidomide

—

Pomalidomide Zentiva 4 mg hard capsules EU/1/24/1830/013-016

Pomalidomide

—

Cite this view

Priya Life Science (2026). Irish Medicines Register, filtered. Derived from the HPRA open dataset. Retrieved 6 October 2026. https://priyalifescience.com/medicines/substance/pomalidomide

Download this register

GET /api/export.php?register=medicines-ie&format=csv Try the JSON export →

Regulatory information only — not medical advice. For the authoritative record see the HPRA register directly.